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Edited by Horst FeldmannAbstract The mechanism of trinucleotide repeat expansion, an
important cause of neuromuscular and neurodegenerative dis-
eases, is poorly understood. We report here on the study of the
role of ﬂap endonuclease 1 (Fen1), a structure-speciﬁc nuclease
with both 5 0 ﬂap endonuclease and 5 0-3 0 exonuclease activity,
in the somatic hypermutability of the (CTG)n Æ (CAG)n repeat
of the DMPK gene in a mouse model for myotonic dystrophy
type 1 (DM1). By intercrossing mice with Fen1 deﬁciency with
transgenics with a DM1 (CTG)n Æ (CAG)n repeat (where
104 6 n 6 110), we demonstrate that Fen1 is not essential for
faithful maintenance of this repeat in early embryonic cleavage
divisions until the blastocyst stage. Additionally, we found that
the frequency of somatic DM1 (CTG)n Æ (CAG)n repeat instabil-
ity was essentially unaltered in mice with Fen1 haploinsuﬃciency
up to 1.5 years of age. Based on these ﬁndings, we propose that
Fen1, despite its role in DNA repair and replication, is not pri-
marily involved in maintaining stability at the DM1 locus.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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and replication1. Introduction
Maintenance of genome stability is of critical importance for
normal growth, viability, and functional homeostasis of cells.
While DNA replication and repair are becoming increasingly
better understood, the molecular events that determine stabil-
ity across long tracts of simple repetitive sequences remain
relatively obscure. Microsatellite instability of mono- or mul-
tinucleotide repeats is a distinguishing feature of certain forms
of cancer and expansion of trinucleotide repeat (TNR)
sequences beyond an unaﬀected range is the direct basis of aAbbreviations: DM1, myotonic dystrophy type 1; Fen1, ﬂap endo-
nuclease 1; TNR, trinucleotide repeat; HD, Huntington’s disease;
SCA, spinocerebellar ataxia
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doi:10.1016/j.febslet.2006.08.059series of hereditary neurodegenerative disorders, including
Huntington’s disease (HD), several spinocerebellar ataxias
(SCAs) and myotonic dystrophy (DM).
Myotonic dystrophy type 1 (DM1) is characterized by mus-
cular dystrophy and myotonia in combination with a highly
variable manifestation of features like cataract, heart conduc-
tion defects, insulin insensitivity and cognitive impairment.
DM1 is caused by the expansion of a (CTG)n repeat in the
3 0 UTR of the DMPK gene on chromosome 19. Once DM1
alleles are in the disease-associated length range (>50 CTGs),
repeat tracts become dramatically unstable. Intergenerational
mutation rates may be almost 100% per generation, with a
strong tendency towards further repeat gains [1–3]. The
DM1 repeat is also somatically unstable and extensive instabil-
ity has been reported in a wide range of human tissues [1,4].
This somatic expansion is mediated by multiple small length
changes in a highly deterministic process which is clearly age
dependent, with longer average DM1 repeat lengths and
broader ranges of variability observed in older patients [3,5].
We know that somatic expansions accumulate in both prolifer-
ating and post-mitotic tissues, suggesting that expansion is cell-
division independent [4,6]. Furthermore, the rate of instability
of the (CTG)n Æ (CAG)n repeat in DM1 is correlated to repeat
length and is probably due to an increased ability of the repeat
sequence to form aberrant DNA structures, like slipped strand
hairpins or cruciforms with single-stranded regions [7]. Failure
to process these structures by mismatch repair proteins – e.g.,
MSH2, MSH3, PMS2 or MLH1 – and/or aberrant activity of
machinery involved in DNA break repair, may underlie muta-
genic instability [8–11]. Cis-acting factors such as nearby pres-
ence of replication origins or proximity of CpG islands may
also inﬂuence instability [12,13].
Our group has developed a knock-in mouse model in which
somatic expansion of the DM1 (CTG)n Æ (CAG)n tract is faith-
fully reproduced. In this model, a human chromosomal seg-
ment spanning the exon 13–15 region of the DMPK gene of
a DM1 patient with a (CTG)84 repeat replaces the cognate
endogenous segment of the mouse DMPK gene [10]. Hence,
this places chromatin embedding of the repeat element and
production of repeat containing DMPK mRNA under ‘‘natu-
ral’’ host control. Study of this model revealed that activity of
the Msh2/Msh3 protein complex is essential for expansion [10].
We report here on the use of this mouse model to study the
involvement of another DNA processing enzyme, Fen1, a
structure-speciﬁc nuclease with both 5 0 ﬂap endonuclease and
5 0 to 3 0 exonuclease activity [14]. On replicating DNA, Fen1blished by Elsevier B.V. All rights reserved.
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tinuous lagging strand synthesis, promoting normal replisome
and DNA fork progression. Fen1 possesses also a speciﬁc gap
endonuclease activity critical for progress of stalled replication
forks. Its activity has furthermore been implicated in repair
processing of DNA in G0-arrested cells, in long patch base
or nucleotide excision and in non-homologous end joining
and recombination [14].
Based on theoretical considerations, a sequence expansion
model has been proposed to explain a role for this enzyme in
destabilization and tendency towards length increase of
(CTG)n Æ (CAG)n repeat tracts [15]. In vitro experiments and
genetic assays in yeast model systems with long (CTG)n Æ
(CAG)n repeats or other types of triplet repeats showed that
presence of the Fen1 homologue Rad27p restrains both the
expansion behavior and the fragility of these DNA repeat mo-
tifs, presumably via its ﬂap degrading ability [16–18]. These
studies showed that Rad27 mutation induces both contractions
and expansions, but does not aﬀect the length-threshold for
repeat expansion [19]. Experimental veriﬁcation for the role
of Fen1 in higher eukaryotes appeared diﬃcult and has
resulted in contrasting ﬁndings regarding its involvement in
(CAG)n Æ (CTG)n triplet repeat expansion in HD [20,21]. In
recent work on SCA7 (CAG)n Æ (CTG)n repeat expansion in
Drosophila no eﬀects of Fen1 absence were observed [22].
We here show that Fen1 absence does not aﬀect faithful
maintenance of the DM1 (CTG)110 repeat in early embryonic
divisions up to the blastocyst stage. Additionally, we found
that the rate of somatic hypermutability was essentially unal-
tered in mice with Fen1 haploinsuﬃciency up to 1.5 years of
age. We propose that Fen1 is not essential for trinucleotide sta-
bility at the DM1 locus.2. Materials and methods
2.1. Targeting vector and mouse generation
Fen1 deﬁcient mice were generated via targeted mutagenesis in ES
cells derived from mouse strain 129/Ola, essentially as described [23].












Fig. 1. Targeted mutation of the Fen1 gene. (A) Strategy for the replacement
exon 2, with the ATG initiation codon right at the beginning, just 5 0 of a ClaI
structure of the targeting vector with the Neo and HSV-TK cassettes, and th
used to amplify the genomic fragment for constructing the targeting vector.
labeled 5 0 and 3 0 – indicate positioning of genomic segments ﬂanking the F
targeting events. (B) Western blot probed with a Fen1 antibody to show Fen1
ES cells. Tubulin antibody staining was used to verify protein loading. Note
ES cell clone, is 50% reduced.from mouse 129/Ola DNA by PCR with Herculase polymerase
(Stratagene) and primers 5 0-CGAAGCTGGGAACGATACTGAAA-
GAACG-30 and 5 0-GGTAAGGCACTTCCTATCCAAGTTCCG-
ATC-3 0 and cloned in a pBS vector. In several cloning steps, a
543 bp ClaI–SbfI internal segment was replaced by a 1178 bp Neo cas-
sette and a HSV-TK cassette was placed downstream (Fig. 1A). The
targeting vector was linearized by KpnI and introduced into ES cells
by electroporation. Screening of G418/FIAU resistant clones was per-
formed by Southern blotting of genomic DNA, after digestion with
BamHI. The 5 0 probe from the upstream ﬂanking genomic segment
was obtained by PCR using primers 5 0-GTTAACTTCCATTGT-
CACTTTC-30 and 5 0-CATAGTGGGCGTTCTTTCTG-3 0; the 3 0
probe downstream of the region of homology was obtained by PCR
using primers 5 0-CAGGATGTGGTAACAGCATT-3 0 and 5 0-CAT-
GTCACAAACAGGAAGGTT-30. One ES cell clone with a correctly
disrupted Fen1 allele and correct karyotype was identiﬁed and injected
into blastocysts to generate germline chimeras. Transmitting males
were mated with C57BL/6 females and F1 pups were screened by tail
biopsy to identify Fen1+/ mice. Fen1+/ mice were crossed with
(CTG)n/(CTG)n mice [10] to obtain Fen1
+///wt/(CTG)n mice. These
mutants were bred to generate Fen1+///(CTG)n/(CTG)n mice, which
were then crossed with Fen1+/ mice to get pregnant females for isola-
tion of morulae and blastocysts carrying one (CTG)n allele and either
no, one or two mutated Fen1 alleles.
2.2. PCR genotyping and analysis of the (CTG)nÆ(CAG)n repeat
Mouse tail DNA was used for PCR genotyping using diagnostic
Fen1 primers 5 0-TACCATGGGAATTCACGGC-30 and 5 0-GCACA-
GATCCACAAACTG-30 (32 cycles). Length typing of the (CTG)n Æ
(CAG)n-containing segment was done by PCR using primers
5 0-GAAGGGTCCTTGTAGCCGGGAA-3 0 and 5 0-GGAGGATG-
GAACACGGACGG-3 0 (32 cycles) followed by analysis in the ALF
DNA sequencing system (Amersham Pharmacia Biotech, Uppsala,
Sweden), as described [10]. Each (CTG)n Æ (CAG)n repeat length proﬁle
was normalized to its highest peak to be able to optimally compare the
relative contribution of fragments with expanded repeats between dif-
ferent proﬁles.
Individual morulae and blastocysts were washed in HEPES-buﬀered
medium and ﬁnally PBS and lysed in 20 ll 1 ·Herculase buﬀer (Strat-
agene) with 60 lg/ml proteinase K for 3 h at 55 C. Proteinase K was
inactivated for 10 min at 99C and 6 ll of the lysis mixture was used as
template in the Fen1 PCR (38 cycles).
2.3. Western blotting
Wt and Fen1+/ ES cells were washed in PBS and lysed in Laemmli
sample buﬀer. Protein lysates were separated by SDS–PAGE and trans-










of part of exon 2 of the Fen1 gene. The entire ORF is contained within
site. Schemes depict the exon–intron arrangement in the Fen1 gene, the
e structure of the targeted allele. Arrows indicate locations of primers
Positions of relevant ClaI, BamHI and SbfI sites are indicated. Bars –
en1 gene, which were used as probes for Southern analysis of correct
protein (42 kDa) levels in whole cell lysates of wt and FEN+/mutant
that the signal representing Fen1 protein level in the correctly targeted
Table 1
Genotyping oﬀspring from Fen1+/ · Fen1+/ crossings
Genotype Morulae (%)a Blastocysts (%)a Newborn pups (%)b
wt 5 (45) 27 (33) 34 (35)
+/ 5 (45) 41 (50) 64 (65)
/ 1 (10) 14 (17) 0 (0)*
Total 11 82 98
aFrom Fen1+/ · Fen1+///(CTG)n/(CTG)n and Fen1+///wt/(CTG)n ·
Fen1+///(CTG)n/(CTG)n crossings, where 104 6 n 6 110.
bFrom Fen1+/ · Fen1+/ crossings.
*P < 0.001, Chi-square test.
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and presence of protein was revealed by ECL detection using standard
protocols.
2.4. Immunohistological analysis of morulae and blastocysts
Oviducts (at 2.5 dpc) or uteri (at 3.5 dpc) of pregnant mice were
ﬂushed with HTF/HEPES (Cambrex BE02-022F), 0.5% BSA solution
(Sigma A-4503) to obtain mouse morulae or blastocysts. The zona pel-
lucida was disrupted with acidic tyrode solution [24] incubation for a
few min. Embryos were caught in a ﬁbrin clot by activating ﬁbrinogen
with thrombin [25]. Fixation was performed with 2% (w/v) formalde-
hyde, 0.15% Triton X-100 in PBS for 30 min. After 1 h at 37 C with
blocking solution including 10% normal goat serum, overnight incuba-
tion with a Fen1 antibody [26] was done at 4 C. Then, coverslips were
incubated for 2 h with Alexa Fluor 488-conjugated secondary antibody
(Molecular Probes), washed, stained with DAPI and embedded.
Images were obtained with a Bio-Rad MRC1024 confocal laser-scan-
ning microscope equipped with an argon/krypton laser, using a 60· 1.4
NA oil objective and LaserSharp2000 acquisition software. Images
were further processed with Adobe Photoshop 7.0. Afterwards, stained
embryos were collected and processed for Fen1 PCR analysis as de-
scribed above. The experiment was performed in triplicate; altogether,
72 embryos were examined.3. Results
3.1. Targeted mutation of the Fen1 gene
A segment of the Fen1 open reading frame was removed in
mouse ES cells via targeted replacement (Fig. 1A). Fen1 pro-
tein levels in targeted ES cells were reduced to 50% of nor-
mal (Fig. 1B), indicating that no compensatory adaptation
of expression of the wt allele had occurred. Fen1+/ mice were
overtly normal during development, adulthood and age-
ing, with a normal fertility proﬁle. In contrast, breeding of
Fen1+/ mice never yielded homozygous oﬀspring, indicating
prenatal lethality (Table 1). Genotyping of preimplantation
embryos suggested that loss already occurred during the mor-
ula and blastocyst stage of gestation, although these ﬁndings
did not reach statistical signiﬁcance (Table 1).Fig. 2. Somatic instability of the (CTG)n Æ (CAG)n repeat in wt and Fen1
+/m
products of genomic DNAs from liver, kidney and skeletal muscle of 6-, 12- a
Arrows indicate the position of the predominant progenitor allele length in
lengths varied between individual mice due to intergenerational instability and
somatic expansion (visible as a shift towards the right) increases with age in a
length proﬁles were pairwise compared between age-matched wt and Fen1+/3.2. Haploinsuﬃciency of Fen1 has no eﬀect on somatic
(CTG)n Æ (CAG)n repeat instability
Earlier, using established procedures for repeat length typing
in diﬀerent tissues of our (CTG)n Æ (CAG)n knock-in model, we
observed extensive somatic instability [10]. Hypermutability of
the repeat was dependent on the mouse background strain, age
and tissue type, with a general tendency to length increase. To
assess the role of Fen1 in this process, we compared repeat pro-
ﬁles in liver, kidney and skeletal muscle of Fen1+///wt/(CTG)n
and wt/(CTG)n mice at 6, 12 or 18 months of age (Fig. 2).
Although we did encounter small diﬀerences in repeat length
proﬁles between individual animals and also sometimes the
fraction of cells involved in a given tissue was diﬀerent, we ob-
served no consistent changes in average allele length or length
spreading between animals in the wt and Fen1+/ cohorts (nine
mouse pairs examined). Collectively, our data indicate that
Fen1 haploinsuﬃciency has neither an eﬀect on the rate of re-
peat length mutation nor on the tendency to length increase of
the (CTG)n Æ (CAG)n transgene.
At this stage, we cannot exclude an eﬀect of Fen1 haploinsuf-
ﬁciency on (CTG)n Æ (CAG)n repeat instability in the germ
line, simply because intergenerational instability occurs at
too low frequency in our lineage [10], and we presumably needice. Representative proﬁles of (CTG)n Æ (CAG)n repeat containing PCR
nd 18-month-old wt/(CTG)n (blue) and Fen1
+///wt/(CTG)n (red) mice.
proﬁles of tail DNAs determined at 3 weeks of age. Progenitor allele
ranged between (CTG)104 and (CTG)110 in the cohort used. Note that
ll three tissues shown, but is most prominent in liver. (CTG)n Æ (CAG)n
animals on one gel, but diﬀerent gels were used for diﬀerent age classes.
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signiﬁcant data would become apparent. What we do know,
however, is that loss of 50% of Fen1 in the germ line is not
associated with an overt increase in intergenerational instabil-
ity (data not shown).
3.3. Early eﬀects of Fen1 deﬁciency?
Given the role of Fen1 in replication and repair, we wished
to determine whether absence of Fen1 had any eﬀect on the
accuracy of replication of the (CTG)n Æ (CAG)n tract in early
embryos. To this end, Fen1+///(CTG)n/(CTG)n mice were
crossed with Fen1+/ or Fen1+///wt/(CTG)n mice and morulae
and blastocysts were collected. Some of the Fen1/ embryos
had an anomalous appearance, suggesting that they would
have been lost before gastrulation. This observation and the
presumed underrepresentation of Fen1/ embryos (Table 1)
are in line with ﬁndings obtained with another Fen1 knock
out model [27]. Larsen et al. suggested that Fen1 knock out
embryos may survive initial cell divisions and develop nor-
mally until maternally supplied Fen1 protein is exhausted
[27]. If this assumption is true, it would be diﬃcult to study
(CTG)n Æ (CAG)n repeat behavior in absence of Fen1, due to
presence of maternal Fen1 in early embryos and embryonic
lethality later on.
To examine this in more detail, we studied Fen1 expression
in early embryogenesis by subjecting morulae and blastocysts
to immunohistological analysis with a Fen1-speciﬁc antiserum.
Comparison of signals in Fen1/ and wt blastocysts revealed
absence of staining in nuclei of Fen1/ blastocysts (Fig. 3),Fig. 3. Fen1 is absent in nuclei of cells in early Fen1/ embryos. Wild typ
immunohistological detection with a Fen1 antiserum (A, C; one optical se
embryos). A clear Fen1 nuclear staining observed in wt embryos was absent
was observed independent of the genotype, which may be caused by binding
after image recording.whereas nuclear immunoﬂuorescence was consistently ob-
served in Fen1+/ blastocysts (data not shown). To us this sug-
gests that the maternal contribution of Fen1 at this stage is
low, if at all existing. However, we must be cautious with this
interpretation as our analyses were hampered by a high cyto-
plasmic background staining, independent of the genotype.
This phenomenon was seen with three independent Fen1 anti-
bodies and may be an eﬀect of epitope sharing with other pro-
teins (data not shown).
Analysis of (CTG)n Æ (CAG)n repeat length in all embryos
that could be genotyped showed a rather narrow distribution
of product lengths, with characteristic sloping at lower and
higher repeat lengths in the proﬁle (Fig. 4). The proﬁles ob-
served were similar to that seen in tail biopsies of the parental
animals at three weeks of age. No diﬀerences in mean repeat
length were observed between wt, Fen1+/ and Fen1/ em-
bryos. Assuming that maternal Fen1 is not a factor in our
analyses, our ﬁndings indicate that Fen1 is not necessary for
faithful replication of the DM1 (CTG)n Æ (CAG)n repeat during
the ﬁrst 4–6 rounds of replication during early embryogenesis.4. Discussion
The propensity of simple (CAG)n Æ (CTG)n, (CCG)n Æ (CGG)n
or (GAA)n Æ (TTC)n TNRs to form highly mutagenic structures
and undergo frequent length expansions has been studied inten-
sively after the recognition that these DNA elements cause
human neurodegenerative diseases, now more than 15 yearse (A, B) and Fen1/ (C, D) embryos were isolated and processed for
ction each) [26]. DNA was counterstained with DAPI (B, D; whole
in Fen1/ embryos (see arrows). A cytoplasmic background staining
of the Fen1 antiserum to cross-reactive proteins. Genotyping was done
Fig. 4. Somatic hypermutability of the (CTG)n Æ (CAG)n repeat in early embryos. (A) (CTG)n Æ (CAG)n length proﬁles were collected from morulae
and blastocysts of diﬀerent genotypes. Three examples are shown for each genotype: wt, FEN+/, and FEN/. (B) Intercomparison between the
width of allelic lengths in proﬁles for embryos of diﬀerent genotypes. (see panel (C) for the method used). From top to bottom proﬁle widths of wt
(n = 11), Fen1+/ (n = 13) and Fen1/ (n = 11) embryos are shown. (C) Illustration of method used to quantify somatic hypermutability in early
embryos. The width of the proﬁle, including all peaks with 25% or more of the signal intensity of the main peak, was determined (horizontal bar).
Peak variation, resulting from strand slippage during the ampliﬁcation reaction or representing true somatic instability ranges in this example from
4 (contractions) to +3 (expansions). To facilitate interembryonic comparison and exclude eﬀects of small gains or losses in progenitor allele length,
the vertical line indicating the position of the main peak (= 100%), was placed at position 0 for each embryo.
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expansion are still not clearly understood. Current models fall
into two categories, based on molecular events involved in
(i) DNA replication or (ii) DNA repair and recombination
[28]. Background knowledge implicated in these models mainly
comes from studies of the biophysical properties of abnormal
DNA structures formed by TNRs in vitro (in the test tube
and in cell extracts), and from studies in vivo in Escherichia coli
and Saccharomyces cerevisiae, which are continuously active in
DNA replication followed by cell division.
Here, we have analyzed how somatic TNR instability in the
(CTG)n Æ (CAG)n repeat associated with DM1 is modulated by
absence or presence of Fen1. Fen1 is a multifunctional enzyme
with a proposed critical role in RNA primer removal and join-
ing of Okazaki fragments during lagging strand DNA synthe-
sis, processing of stalled DNA replication forks, long-patch
base excision repair, and recombination and resolution of mis-
aligned hairpin and bubble structures in di- and trinucleotiderepeats [7]. Based on these functions, Fen1 has long been con-
sidered a good candidate for being involved in (CTG)n Æ
(CAG)n repeat instability in DM1, HD or SCA7 [15,22]. In
yeast model systems, absence of Rad27 renders repeat elements
profoundly unstable [16–19,29]. However, ﬁndings in yeast
should not be simply extrapolated for prediction of TNR
maintenance in mammals. Yeast cells may not be ideal models
as TNRs do not appear as natural elements in their DNA and
mechanisms for repeat maintenance have not been evolution-
arily tested in context in this species. Moreover, genetic assays
in mutant yeasts are virtually always done under conditions of
active growth. For this reason, Rad27 mutants cannot be
regarded as faithful models to reproduce the situation in G0-
arrested cells in mature somatic tissues of mammals. For these
and obvious other reasons, we have tested Fen1’s involvement
in embryos and adult animals of a mouse knock-in strain
with a DMPK gene carrying a humanized 3 0 segment with
expanded (CTG)n Æ (CAG)n repeat. Originally, the (CTG)n Æ
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as repeat length has slowly but steadily increased over 20 suc-
cessive generations, the repeat length was 104–110 CTGs at the
time of intercrossing for this study. Previously, we have
already reported that somatic hypermutability occurred at
high frequency in our model, with doubling of allele length
occurring mainly in adulthood and at old age in tissues like
kidney, stomach and liver [10].
Although slight variations in genetic background (mixed
C3H-129/Ola-C57BL/6) are not accounted for in our analyses,
we conclude that the normal frequency of somatic instability
in our model has not changed in a background of Fen1 hap-
loinsuﬃciency. Also no eﬀects were seen in the timing of onset
of repeat expansion, which undergoes a strong boost after
three to four months of age (data not shown). Thus, we ten-
tatively conclude, that maintenance of proper Fen1 protein
levels is not critical for suppression of (CTG)n Æ (CAG)n repeat
instability. Obviously, also no other large-scale repair eﬀects
on anomalously paired tracts in the repeat area have been
superimposed, as could theoretically have been expected for
endogenously induced long-patch base excision repair or other
repair events on repeat DNA structures for which normal
Fen1 levels would have been required. Indirectly, these obser-
vations argue against a prominent role for Fen1 in somatic
repeat instability. Our ﬁndings corroborate observations in a
HD mouse model with an expanded (CAG)n Æ (CTG)n repeat
[21]. Studies about Fen1 eﬀects on intergenerational TNR
repeat expansion are obviously more controversial. Earlier,
based on the analysis of mutations or polymorphisms within
the Fen1 gene, Fen1 was excluded as candidate gene impli-
cated in intergenerational (CAG)n repeat expansion in families
with HD [20]. However, because only normal Fen1 genes were
observed, the actual role of Fen1 in (CTG)n Æ (CAG)n mainte-
nance was not correctly addressed in this study. In contrast,
minor eﬀects on instability in progeny, limited to the develop-
ing germ cells, have been reported for the HD mouse model
[21], but also in this study eﬀects were only marginally signif-
icant.
To avoid further confusion about the role of Fen1 in TNR
hypermutability, we deliberately conﬁned a large part of our
study to the analysis of repeat fate in adult somatic tissues.
Our ﬁndings should be interpreted with caution, however, as
study of repeat behavior in complete absence of Fen1 is not
possible at this stage of life, because Fen1 deﬁciency is early
lethal in mammals [27,30]. With reduction of Fen1 expression
to 50% of normal levels, the pathogenic threshold for faithful
DNA replication may simply not be reached, but further low-
ering of Fen1 level in the whole animal context is technologi-
cally much more demanding if not entirely impossible.
Apparently, other enzymes that can handle complex DNA
structures with unpaired strand regions – e.g., DNA2, EXO1
or SRS2 – cannot subserve Fen1 in correcting the loss of rep-
lication/repair/recombination function in early embryos. What
then explains Fen1 signiﬁcance in preventing the extent and
timing of cell death in the early mouse embryos? Fen1 ap-
peared not essential for DNA maintenance and replication in
vertebrate DT40 cells [31]. Knockout in yeast also did not
cause lethality [29]. More study will thus be necessary to pre-
cisely pinpoint what renders preimplantation embryos at the
morula/blastocyst stage so highly vulnerable in the absence
of Fen1.Larsen and co-workers suggested an involvement of S-phase
entry block and surmised that presence of a maternal Fen1
pool from oocytes may help embryo survival through the ﬁrst
cell cleavages [27]. Our immunohistological observations with
polyvalent antibodies against Fen1 argue against this possibil-
ity, as Fen1 protein was undetectable in nuclei in embryos with
a homozygous gene deletion. In contrast, Fen1 staining was
visible in the cell nuclei of heterozygous and wild type em-
bryos. One diﬃculty with this analysis was that we observed
a high cytosolic background staining in cells in all embryos.
This makes interpretation somewhat diﬃcult as residual
maternal Fen1 may hide under the cytosolic background stain-
ing. Qiu et al. [32] have reported that Fen1 shuttles between
cytosol and nucleus, and that nuclear localization is cell-cycle
and DNA-state dependent. We consider it unlikely, however,
that cytosolic translocation would completely and synchro-
nously hide Fen1 signal in all cells in our Fen1/ embryos,
as this was never observed in embryos with at least one intact
Fen1 allele. Taken together, a more plausible explanation is
that the bulk of protein in morulae/blastocysts is embryoni-
cally expressed and not of maternal origin. This interpretation
is supported by our observation that Fen1 protein is promi-
nently expressed in ES cells – i.e., a stage corresponding to
those of inner mass cells of early embryos. Furthermore, also
large-scale analysis of the mouse transcriptome indicates that
Fen1 expression strongly increases during early embryogenesis
[33].
Our repeat length analysis did not reveal any diﬀerences in
proﬁles between wt, Fen1+/ or Fen1/ embryos. Assuming
that the lack of nuclear Fen1 staining in Fen1/ embryos
indeed reﬂects complete absence of Fen1 protein during the en-
tire initial state of embryogenesis, this suggests that Fen1’s role
is completely dispensable, or at least that the enzyme is not
very frequently used for DNA ﬂap processing, hairpin process-
ing or maintenance of replication fork progression across the
DM1 repeat tract during the initial cell divisions in early
embryos. Our ﬁndings concerning the role of Fen1 in early em-
bryos and aged tissues in mature animals are thus congruent.
Further analyses are necessary to reveal if replication and
repair complexes and topology of the DM1 (CTG)n Æ (CAG)n
repeat are indeed of similar nature in early embryonic and ter-
minally diﬀerentiated cells. The use of conditional knockout
strategies to ablate Fen1 completely from speciﬁc somatic cells
late in development should therefore be considered. More de-
tailed study is also imperative to allow further comparison of
eﬀects of exonuclease and endonuclease activities of Rad27/
Rth1, and cell state and growth eﬀects, between yeast and mur-
ine models containing (CTG)n Æ (CAG)n repeats [14,16–19,29].
In summary, we provide here genetic evidence that Fen1
activity is not a primary factor involved in somatic TNR insta-
bility in a DM1 mouse model.
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